<DOC>
	<DOC>NCT02637232</DOC>
	<brief_summary>The aim of the study is to evaluate the level of satisfaction among patients to whom Mirvaso® / Onreltea TM (trade mark) is prescribed.</brief_summary>
	<brief_title>Mirvaso® Utilisation and Patient Satisfaction Evaluation (MUSE)</brief_title>
	<detailed_description />
	<mesh_term>Rosacea</mesh_term>
	<mesh_term>Brimonidine Tartrate</mesh_term>
	<criteria>Patients to whom the physician has already decided to prescribe Mirvaso® /OnrelteaTM according to package insert</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>